Download PDF
Semin Respir Crit Care Med 2012; 33(05): 440-449
DOI: 10.1055/s-0032-1325155
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Current Status of Idiopathic Nonspecific Interstitial Pneumonia

Venerino Poletti
1   Department of Thoracic Diseases, GB Morgagni Hospital, Forlì, Italy
,
Micaela Romagnoli
1   Department of Thoracic Diseases, GB Morgagni Hospital, Forlì, Italy
,
Sara Piciucchi
2   Department of Radiology, GB Morgagni Hospital, Forlì, Italy
,
Marco Chilosi
3   Department of Pathology, University of Verona, Verona, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
21 September 2012 (online)

    Permissions and Reprints

Abstract

Pulmonary pathologists were aware of cases of idiopathic interstitial pneumonia (IIP) that morphologically did not fit Liebow's classification scheme. These cases were labeled as “cellular interstitial pneumonia” or “chronic interstitial pneumonia not otherwise specified.” The term nonspecific interstitial pneumonia (NSIP) was first used in relation to a pattern of lung interstitial inflammation seen in association with human immunodeficiency virus (HIV) infection. In 1994 NSIP was used to indicate a group of subacute or chronic interstitial pneumonias characterized morphologically by interstitial inflammation or fibrosis or both, with preservation of the lung architecture and the absence of typical findings for any of the other main categories of IIP (mainly usual interstitial pneumonia, desquamative interstitial pneumonia, and bronchiolitis obliterans organizing pneumonia). Although these patients presented with “nonspecific” lung histology (categorized as cellular and fibrotic variants), and with a broad spectrum of associated clinical conditions, such as connective tissue diseases (CTDs), environmental exposure, and previous acute lung injury, they showed some peculiar clinical aspects, including favorable response to corticosteroid treatment and overall good prognosis.

The clinical and radiographic profiles were better defined in the last decade. The NSIP pattern is the histological background of a subacute/chronic interstitial pneumonitis that may be observed in many conditions, including CTD, drug-induced lung disease, hypersensitivity pneumonitis, slowly healing diffuse alveolar damage (DAD), relapsing organizing pneumonia, occupational exposure, immunodeficiency (mainly HIV infection), graft versus host disease (GVHD), familial pulmonary fibrosis, immunoglobulin G4 (IgG4)-related sclerosing disease, with or without overlap features with Rosai-Dorfman disease, multicentric Castleman disease, and myelodysplastic syndrome. Rarely, NSIP is the histology recognized in patients with idiopathic interstitial pneumonitis, in whom efforts to find potential causative exposures are futile. This entity occurs mostly in middle-aged, never-smoker women, with a likely association with an autoimmune background. High-resolution computed tomographic (HRCT) scans typically demonstrate ground-glass attenuation with a bibasilar distribution, or in the fibrotic variant, ground-glass attenuation along with reticular lines and traction bronchiectasis. The prognosis is good compared with idiopathic pulmonary fibrosis (IPF), and therapeutic options include mainly corticosteroids and immunosuppressive agents. Recently a more precise definition of clinical profiles and radiographic findings of idiopathic NSIP allows consideration of less invasive diagnostic procedures (bronchoalveolar lavage, transbronchial lung biopsy). Better understanding of pathogenetic mechanisms might widen the therapeutic horizon giving a role to new therapeutic options in more severe cases.

Keywords

idiopathic nonspecific interstitial pneumonia - clinical classification - high-resolution CT scan - bronchoalveolar lavage - transbronchial lung biopsy - cyclophosphamide - rituximab
 

  • References

  • 1 Liebow AA, Carrington CB. The interstitial pneumonias. In: Simon M, Potchen EJ, LeMay M, , eds. Frontiers of Pulmonary Radiology: Pathophysiologic, Roentgenographic and Radioisotopic Considerations. New York: Grune & Stratton; 1969: 102-141
    Google Scholar
  • 2 Kuhn C. Chronic infiltrative lung disease: new insights in pathology. The Fleischner Society. 26th Annual Conference on Chest Disease; Vancouver, British Columbia; 1996:25–34
    PubMedGoogle Scholar
  • 3 Kitaichi M. Pathologic features and the classification of interstitial pneumonia of unknown etiology. Bull Chest Dis Res Inst Kyoto Univ 1990; 23 (1-2) 1-18
    PubMedGoogle Scholar
  • 4 Colby TV, Carrington CB. Infiltrative lung disease. In: Thurlbeck WM, , ed. Pathology of the Lung. New York: Thieme; 1988: 425-517
    Google Scholar
  • 5 Ognibene FP, Masur H, Rogers P , et al. Nonspecific interstitial pneumonitis without evidence of Pneumocystis carinii in asymptomatic patients infected with human immunodeficiency virus (HIV). Ann Intern Med 1988; 109 (11) 874-879
    CrossrefPubMedGoogle Scholar
  • 6 Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994; 18 (2) 136-147
    CrossrefPubMedGoogle Scholar
  • 7 Lee JW, Lee KS, Lee HY , et al. Cryptogenic organizing pneumonia: serial high-resolution CT findings in 22 patients. AJR Am J Roentgenol 2010; 195 (4) 916-922
    CrossrefPubMedGoogle Scholar
  • 8 Shrestha B, Sekiguchi H, Colby TV , et al. Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am J Surg Pathol 2009; 33 (10) 1450-1462
    CrossrefPubMedGoogle Scholar
  • 9 Farris III AB, Hasserjian RP, Zukerberg LR , et al. Diffuse cellular and fibrosing interstitial pneumonitis with desquamative interstitial pneumonitis-like features associated with myeloid neoplasia. Am J Surg Pathol 2009; 33 (10) 1485-1493
    CrossrefPubMedGoogle Scholar
  • 10 Travis WD, Hunninghake G, King Jr TE , et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 2008; 177 (12) 1338-1347
    CrossrefPubMedGoogle Scholar
  • 11 Kinder BW, Collard HR, Koth L , et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?. Am J Respir Crit Care Med 2007; 176 (7) 691-697
    CrossrefPubMedGoogle Scholar
  • 12 Romagnoli M, Nannini C, Piciucchi S , et al. Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders?. Eur Respir J 2011; 38 (2) 384-391
    CrossrefPubMedGoogle Scholar
  • 13 Travis WD, Matsui K, Moss J, Ferrans VJ. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000; 24 (1) 19-33
    CrossrefPubMedGoogle Scholar
  • 14 Reghellin D, Poletti V, Tomassett S , et al. Cathepsin K is a sensitive immunohistochemical marker for detection of micro-granulomas in hypersensitivity pneumonitis. Sarcoidosis Vasc Diffuse Lung Dis 2010; 27 (1) 57-63
    PubMedGoogle Scholar
  • 15 Chilosi M, Poletti V, Murer B , et al. Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63. Lab Invest 2002; 82 (10) 1335-1345
    CrossrefPubMedGoogle Scholar
  • 16 Chilosi M, Zamò A, Doglioni C , et al. Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis. Respir Res 2006; 7: 95
    CrossrefPubMedGoogle Scholar
  • 17 Tansey D, Wells AU, Colby TV , et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004; 44 (6) 585-596
    CrossrefPubMedGoogle Scholar
  • 18 de Carvalho EF, Parra ER, de Souza R, A'b Saber AM, Machado JdeC, Capelozzi VL. Arterial and interstitial remodelling processes in non-specific interstitial pneumonia: systemic sclerosis versus idiopathic. Histopathology 2008; 53 (2) 195-204
    CrossrefPubMedGoogle Scholar
  • 19 Kim DS, Yoo B, Lee JS , et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19 (2) 121-127
    PubMedGoogle Scholar
  • 20 Yousem SA. The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. Hum Pathol 1995; 26 (6) 668-675
    CrossrefPubMedGoogle Scholar
  • 21 Flaherty KR, Travis WD, Colby TV , et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001; 164 (9) 1722-1727
    CrossrefPubMedGoogle Scholar
  • 22 Nicholson AG, Addis BJ, Bharucha H , et al. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax 2004; 59 (6) 500-505
    CrossrefPubMedGoogle Scholar
  • 23 Poletti V, Kitaichi M. Facts and controversies in the classification of idiopathic interstitial pneumonias. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17 (3) 229-238
    PubMedGoogle Scholar
  • 24 Watanabe K, Higuchi K, Ninomiya K , et al. Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia. Eur Respir J 2002; 20 (5) 1213-1219
    CrossrefPubMedGoogle Scholar
  • 25 Romagnoli M, Bigliazzi C, Casoni GL , et al. The role of transbronchial lung biopsy for the diagnosis of diffuse drug-induced lung disease: a case series of 44 patients. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25 (1) 36-45
    PubMedGoogle Scholar
  • 26 Casoni GL, Gurioli C, Chhajed PN , et al. The value of transbronchial lung biopsy using jumbo forceps via rigid bronchoscope in diffuse lung disease. Monaldi Arch Chest Dis 2008; 69 (2) 59-64
    PubMedGoogle Scholar
  • 27 Babiak A, Hetzel J, Krishna G , et al. Transbronchial cryobiopsy: a new tool for lung biopsies. Respiration 2009; 78 (2) 203-208
    CrossrefPubMedGoogle Scholar
  • 28 Ohshimo S, Bonella F, Cui A , et al. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 179 (11) 1043-1047
    CrossrefPubMedGoogle Scholar
  • 29 Ryu YJ, Chung MP, Han J , et al. Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias. Respir Med 2007; 101 (3) 655-660
    CrossrefPubMedGoogle Scholar
  • 30 Welker L, Jörres RA, Costabel U, Magnussen H. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 2004; 24 (6) 1000-1006
    CrossrefPubMedGoogle Scholar
  • 31 Veeraraghavan S, Latsi PI, Wells AU , et al. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur Respir J 2003; 22 (2) 239-244
    CrossrefPubMedGoogle Scholar
  • 32 Kim EY, Lee KS, Chung MP, Kwon OJ, Kim TS, Hwang JH. Nonspecific interstitial pneumonia with fibrosis: serial high-resolution CT findings with functional correlation. AJR Am J Roentgenol 1999; 173 (4) 949-953
    CrossrefPubMedGoogle Scholar
  • 33 MacDonald SL, Rubens MB, Hansell DM , et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001; 221 (3) 600-605
    CrossrefPubMedGoogle Scholar
  • 34 Hozumi H, Nakamura Y, Johkoh T , et al. Nonspecific interstitial pneumonia: prognostic significance of high-resolution computed tomography in 59 patients. J Comput Assist Tomogr 2011; 35 (5) 583-589
    CrossrefPubMedGoogle Scholar
  • 35 Souza CA, Müller NL, Lee KS, Johkoh T, Mitsuhiro H, Chong S. Idiopathic interstitial pneumonias: prevalence of mediastinal lymph node enlargement in 206 patients. AJR Am J Roentgenol 2006; 186 (4) 995-999
    CrossrefPubMedGoogle Scholar
  • 36 Ambrosini V, Zompatori M, De Luca F , et al. 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results. J Nucl Med 2010; 51 (12) 1950-1955
    CrossrefPubMedGoogle Scholar
  • 37 American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165 (2) 277-304
    CrossrefPubMedGoogle Scholar
  • 38 Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, Colby TV. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998; 12 (5) 1010-1019
    CrossrefPubMedGoogle Scholar
  • 39 Meliconi R, Bestagno M, Sturani C , et al. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease. Clin Exp Immunol 1989; 76 (2) 184-189
    PubMedGoogle Scholar
  • 40 Nakos G, Adams A, Andriopoulos N. Antibodies to collagen in patients with idiopathic pulmonary fibrosis. Chest 1993; 103 (4) 1051-1058
    CrossrefPubMedGoogle Scholar
  • 41 Yamadori I, Fujita J, Bandoh S , et al. Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjögren's syndrome. Rheumatol Int 2002; 22 (3) 89-92
    CrossrefPubMedGoogle Scholar
  • 42 Tzelepis GE, Toya SP, Moutsopoulos HM. Occult connective tissue diseases mimicking idiopathic interstitial pneumonias. Eur Respir J 2008; 31 (1) 11-20
    CrossrefPubMedGoogle Scholar
  • 43 Sato T, Fujita J, Yamadori I , et al. Non-specific interstitial pneumonia; as the first clinical presentation of various collagen vascular disorders. Rheumatol Int 2006; 26 (6) 551-555
    CrossrefPubMedGoogle Scholar
  • 44 Park IN, Jegal Y, Kim DS , et al. Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J 2009; 33 (1) 68-76
    CrossrefPubMedGoogle Scholar
  • 45 Fujita J, Ohtsuki Y, Yoshinouchi T , et al. Idiopathic non-specific interstitial pneumonia: as an “autoimmune interstitial pneumonia”. Respir Med 2005; 99 (2) 234-240
    CrossrefPubMedGoogle Scholar
  • 46 Vancheri C, Failla M, Crimi N, Raghu G. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J 2010; 35 (3) 496-504
    CrossrefPubMedGoogle Scholar
  • 47 Chilosi M, Poletti V, Rossi A. The pathogenesis of COPD and IPF: distinct horns of the same devil?. Respir Res 2012; 13: 3
    CrossrefPubMedGoogle Scholar
  • 48 Cottin V, Nunes H, Brillet PY , et al; Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26 (4) 586-593
    CrossrefPubMedGoogle Scholar
  • 49 Marten K, Milne D, Antoniou KM , et al. Non-specific interstitial pneumonia in cigarette smokers: a CT study. Eur Radiol 2009; 19 (7) 1679-1685
    CrossrefPubMedGoogle Scholar
  • 50 Washko GR, Hunninghake GM, Fernandez IE , et al; COPDGene Investigators. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011; 364 (10) 897-906
    CrossrefPubMedGoogle Scholar
  • 51 Samara KD, Margaritopoulos G, Wells AU, Siafakas NM, Antoniou KM. Smoking and pulmonary fibrosis: novel insights. Pulm Med 2011; 2011: 461439 . Epub 2011 Jun 15
    PubMedGoogle Scholar
  • 52 Chilosi M, Doglioni C, Murer B, Poletti V. Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2010; 27 (1) 7-18
    PubMedGoogle Scholar
  • 53 Königshoff M, Dumitrascu R, Udalov S , et al. Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention. Thorax 2010; 65 (11) 949-955
    CrossrefPubMedGoogle Scholar
  • 54 Casoni GL, Ulivi P, Mercatali L , et al. Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis. Int J Biol Markers 2010; 25 (4) 229-235
    PubMedGoogle Scholar
  • 55 Jinta T, Miyazaki Y, Kishi M , et al. The pathogenesis of chronic hypersensitivity pneumonitis in common with idiopathic pulmonary fibrosis: expression of apoptotic markers. Am J Clin Pathol 2010; 134 (4) 613-620
    CrossrefPubMedGoogle Scholar
  • 56 Watanabe K, Handa T, Tanizawa K , et al. Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. Respir Med 2011; 105 (8) 1238-1247
    CrossrefPubMedGoogle Scholar
  • 57 Okayasu K, Ohtani Y, Takemura T , et al. Nonspecific interstitial pneumonia (NSIP) associated with anti-KS antibody: differentiation from idiopathic NSIP. Intern Med 2009; 48 (15) 1301-1306
    CrossrefPubMedGoogle Scholar
  • 58 Okamoto M, Hoshino T, Kitasato Y , et al. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J 2011; 37 (5) 1119-1127
    CrossrefPubMedGoogle Scholar
  • 59 Baroni SS, Santillo M, Bevilacqua F , et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006; 354 (25) 2667-2676
    CrossrefPubMedGoogle Scholar
  • 60 Martinez FJ, Flaherty KR. Nonspecific interstitial pneumonia. In: Schwarz MI, King TE, , eds. Interstitial Lung Disease. 5th ed. Shelton, CT: People's Medical Publishing House; 2011: 945-959
    Google Scholar
  • 61 Schneider F, Hwang DM, Gibson K, Yousem SA. Nonspecific interstitial pneumonia: a study of 6 patients with progressive disease. Am J Surg Pathol 2012; 36 (1) 89-93
    CrossrefPubMedGoogle Scholar
  • 62 Gaxiola M, Buendía-Roldán I, Mejía M , et al. Morphologic diversity of chronic pigeon breeder's disease: clinical features and survival. Respir Med 2011; 105 (4) 608-614
    CrossrefPubMedGoogle Scholar
  • 63 Lee JY, Chung JH, Lee YJ , et al. Propylthiouracil-induced nonspecific interstitial pneumonia. Chest 2011; 139 (3) 687-690
    CrossrefPubMedGoogle Scholar
  • 64 Sattler F, Nichols L, Hirano L , et al. Nonspecific interstitial pneumonitis mimicking Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1997; 156 (3 Pt 1) 912-917
    CrossrefPubMedGoogle Scholar
  • 65 Yu H, Fujita J, Higa F , et al. Nonspecific interstitial pneumonia pattern as pulmonary involvement in human T-cell lymphotropic virus type 1 carriers. J Infect Chemother 2009; 15 (5) 284-287
    CrossrefPubMedGoogle Scholar
  • 66 Chilosi M, Zinzani PL, Poletti V. Lymphoproliferative lung disorders. Semin Respir Crit Care Med 2005; 26 (5) 490-501
    Article in Thieme ConnectPubMedGoogle Scholar
  • 67 Latsi PI, du Bois RM, Nicholson AG , et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003; 168 (5) 531-537
    CrossrefPubMedGoogle Scholar
  • 68 Silva CI, Müller NL, Hansell DM, Lee KS, Nicholson AG, Wells AU. Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time. Radiology 2008; 247 (1) 251-259
    CrossrefPubMedGoogle Scholar
  • 69 Hartman TE, Swensen SJ, Hansell DM , et al. Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology 2000; 217 (3) 701-705
    CrossrefPubMedGoogle Scholar
  • 70 Bnà C, Zompatori M, Poletti V , et al. Differential diagnosis between usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP) assessed by high-resolution computed tomography (HRCT). Radiol Med (Torino) 2005; 109 (5-6) 472-487
    PubMedGoogle Scholar
  • 71 Romagnoli M, Gurioli C, Casoni G, Poletti V. Surgical lung biopsy in the diagnosis of idiopathic NSIP: do we always need it in the initial approach?. Am J Respir Crit Care Med 2009; 179 (11) 1071 , author reply 1071–1072
    CrossrefPubMedGoogle Scholar
  • 72 Sakamoto S, Homma S, Mun M, Fujii T, Kurosaki A, Yoshimura K. Acute exacerbation of idiopathic interstitial pneumonia following lung surgery in 3 of 68 consecutive patients: a retrospective study. Intern Med 2011; 50 (2) 77-85
    CrossrefPubMedGoogle Scholar
  • 73 Bjoraker JA, Ryu JH, Edwin MK , et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157 (1) 199-203
    CrossrefPubMedGoogle Scholar
  • 74 Nicholson AG, Colby TV, du Bois RM, Hansell DM, Wells AU. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000; 162 (6) 2213-2217
    CrossrefPubMedGoogle Scholar
  • 75 Suda T, Kono M, Nakamura Y , et al. Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). Respir Med 2010; 104 (10) 1527-1534
    CrossrefPubMedGoogle Scholar
  • 76 Corte TJ, Copley SJ, Desai SR , et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J 2012; 39 (3) 661-668
    CrossrefPubMedGoogle Scholar
  • 77 Flaherty KR, Martinez FJ. Nonspecific interstitial pneumonia. Semin Respir Crit Care Med 2006; 27 (6) 652-658
    Article in Thieme ConnectPubMedGoogle Scholar
  • 78 Jegal Y, Kim DS, Shim TS , et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005; 171 (6) 639-644
    CrossrefPubMedGoogle Scholar
  • 79 Akira M, Inoue Y, Arai T, Okuma T, Kawata Y. Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia. Thorax 2011; 66 (1) 61-65
    CrossrefPubMedGoogle Scholar
  • 80 Park IN, Kim DS, Shim TS , et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007; 132 (1) 214-220
    CrossrefPubMedGoogle Scholar
  • 81 Suda T, Kaida Y, Nakamura Y , et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med 2009; 103 (6) 846-853
    CrossrefPubMedGoogle Scholar
  • 82 Cottin V, Donsbeck AV, Revel D, Loire R, Cordier JF. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 1998; 158 (4) 1286-1293
    CrossrefPubMedGoogle Scholar
  • 83 Kondoh Y, Taniguchi H, Yokoi T , et al. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Eur Respir J 2005; 25 (3) 528-533
    CrossrefPubMedGoogle Scholar
  • 84 Nanki N, Fujita J, Yamaji Y , et al. Nonspecific interstitial pneumonia/fibrosis completely recovered by adding cyclophosphamide to corticosteroids. Intern Med 2002; 41 (10) 867-870
    CrossrefPubMedGoogle Scholar
  • 85 Flaherty KR, Toews GB, Lynch III JP , et al. Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. Am J Med 2001; 110 (4) 278-282
    CrossrefPubMedGoogle Scholar
  • 86 Raghu G, Collard HR, Egan JJ , et al; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183 (6) 788-824
    CrossrefPubMedGoogle Scholar
  • 87 Corte TJ, Ellis R, Renzoni EA , et al. Use of intravenous cyclophosphamide in known or suspected, advanced non-specific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2009; 26 (2) 132-138
    PubMedGoogle Scholar
  • 88 Keir GJ, Maher TM, Hansell DM , et al. Severe interstitial lung disease in connective tissue disease: Rituximab as rescue therapy. Eur Respir J 2012; Feb 9. [Epub ahead of print]
    PubMedGoogle Scholar
  • 89 Khan ML, Colby TV, Viggiano RW, Fonseca R. Treatment with bortezomib of a patient having hyper IgG4 disease. Clin Lymphoma Myeloma Leuk 2010; 10 (3) 217-219
    CrossrefPubMedGoogle Scholar
  • 90 Kawabata Y, Takemura T, Hebisawa A , et al. Eosinophilia in bronchoalveolar lavage fluid and architectural destruction are features of desquamative interstitial pneumonia. Histopathology 2008; 52 (2) 194-202
    PubMedGoogle Scholar
  • 91 Fell CD, Martinez FJ, Liu LX , et al. Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010; 181 (8) 832-837
    CrossrefPubMedGoogle Scholar